From: A risk score system to timely manage treatment in Crohn’s disease: a cohort study
N | % | Median | IQR | ||
---|---|---|---|---|---|
Gender | Female | 93 | 58.1 | ||
Age at diagnosis | 31 | (22.8–42.6) | |||
Age at study enrollment | 40 | (29.1–53.8) | |||
Years from diagnosis to study enrollment | 6.0 | (1.3–11.3) | |||
Smoker at diagnosis | Yes | 91 | 56.9 | ||
Smoker at study enrollment | Yes | 74 | 46.2 | ||
Family history | Yes | 19 | 11.9 | ||
Disease Behavior | B1 | 40 | 25.0 | ||
B2 | 89 | 55.6 | |||
B3 | 31 | 19.4 | |||
Disease Location | L1 | 98 | 61.3 | ||
L2 | 10 | 6.3 | |||
L3 | 51 | 31.9 | |||
L4 | 1 | 0.6 | |||
Steroids at first flare-up | Yes | 50 | 31.2 | ||
Perianal Disease at diagnosis | Yes | 46 | 28.8 | ||
Perianal Disease at study enrollment | Yes | 15 | 9.4 | ||
Previous surgery | Yes | 53 | 33.1 | ||
Number of surgery at study enrollment | 1 | 34 | |||
≥ 2 | 19 | ||||
Extension of intestine resected a (cm) | 30 | (20–40) | |||
Type of anastomosisa | L-L | 28 | 52.8 | ||
T-L | 11 | 20.8 | |||
T-T | 10 | 18.9 | |||
Stoma | 1 | 1.9 | |||
Abdominal symptoms | Yes | 71 | 44.4 | ||
Serological inflammatory markers | Yes | 94 | 58.8 | ||
Extra-intestinal disease | Yes | 27 | 16.9 | ||
Use of azathioprine | Yes | 29 | 18.1 | ||
Use of corticosteroids at first flare-up | Yes | 50 | 31.2 | ||
Use of anti-TNF- α drugs | Yes | 15 | 9.4 | ||
SICUS FINDINGS | |||||
• Site of CD lesion | No lesions | 18 | 11.2 | ||
Ileal | 142 | 88.8 | |||
ICA | 0 | 0.0 | |||
• Intestinal wall thickness (mm) | 8 | (5–10) | |||
• Extension of CD lesion (cm) | 25 | (9–35) | |||
• Presence of strictures | Yes | 83 | 51.9 | ||
• Presence of fistulas | Yes | 29 | 18.1 | ||
• Presence of abscesses | Yes | 12 | 7.5 | ||
• Presence of MFH | Yes | 38 | 23.8 | ||
• Presence of enlarged nodes | Yes | 14 | 8.8 | ||
• Presence of enlarged spleen | Yes | 34 | 21.3 | ||
BMI | 22 | (19.6–25.3) | |||
CDAI | 54 | (24–96) |